Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: A cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Hor, Kan N ^a   Mazur, Wojciech ^b   Taylor, Michael D ^a   Al Khalidi, Hussein R ^c   Cripe, Linda H ^a   Jefferies, John L ^a   Raman, Subha V ^d   Chung, Eugene S ^b   Kinnett, Kathi J ^a   Williams, Katelyn ^a   Gottliebson, William M ^a   Benson, D Woodrow ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHRIST HOSPITAL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LISINOPRIL; LOSARTAN; PREDNISONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; CROSS-SECTIONAL STUDY; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; ENZYME INHIBITION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART RHYTHM; HEART STRESS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; ADOLESCENT; ANALYSIS OF VARIANCE; CARDIOMYOPATHY; COMPARATIVE STUDY; DISEASE COURSE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHIES; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HEART RATE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING, CINE; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL CONTRACTION; OHIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84857668964     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-60     Document Type: Article

References (50)

1. Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987. Hoffman EP, Brown RH, Kunkel LM, Biotechnology 1992 24 457 466 1422053
2. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA, Proc Natl Acad Sci USA 1985 82 4778 4782 10.1073/pnas.82.14.4778 2991893 (Pubitemid 16242974)
3. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Ray PN, Belfall B, Duff C, Logan C, Kean V, Thompson MW, Sylvester JE, Gorski JL, Schmickel RD, Worton RG, Nature 1985 318 672 675 10.1038/318672a0 3001530 (Pubitemid 16172419)
4. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R, Neuromuscul Disord 2004 14 526 534 10.1016/j.nmd.2004.05.006 15336694 (Pubitemid 39141708)
5. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, et al. Am J Respir Crit Care Med 2004 170 456 465 15302625 (Pubitemid 39214623)
6. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH, Pediatr Cardiol 2005 26 768 771 10.1007/s00246-005-0909-4 15990951 (Pubitemid 43130167)
7. [Cardiac manifestation of progressive muscular dystrophy of the Duchenne type]. Angermann C, Spes C, Pongratz D, Z Kardiol 1986 75 542 551 3788261 (Pubitemid 16023217)
8. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. de Kermadec JM, Becane HM, Chenard A, Tertrain F, Weiss Y, Am Heart J 1994 127 618 623 10.1016/0002-8703(94)90672-6 8122611 (Pubitemid 24124693)
9. Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy. Markham LW, Michelfelder EC, Border WL, Khoury PR, Spicer RL, Wong BL, Benson DW, Cripe LH, J Am Soc Echocardiogr 2006 19 865 871 10.1016/j.echo.2006.02.003 16824995 (Pubitemid 43977862)
10. The heart in muscular dystrophy. Markham LW, Spicer RL, Cripe LH, Pediatr Ann 2005 34 531 535 16092627 (Pubitemid 41073053)
11. Depressed left ventricular contractile reserve diagnosed by dobutamine stress echocardiography in a patient with Duchenne muscular dystrophy. Wong BL, Mukkada VA, Markham LW, Cripe LH, J Child Neurol 2005 20 246 248 15832620 (Pubitemid 40561775)
12. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Fong PY, Turner PR, Denetclaw WF, Steinhardt RA, Science 1990 250 673 676 10.1126/science.2173137 2173137 (Pubitemid 120034287)
13. Autopsy analyses of the muscular dystrophies. Moriuchi T, Kagawa N, Mukoyama M, Hizawa K, Tokushima J Exp Med 1993 40 83 93 8211986
14. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E, Gottliebson WM, Int J Cardiovasc Imaging 2009 25 57 63 10.1007/s10554-008-9352-y 18686011
15. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE, J Am Coll Cardiol 2007 49 1874 1879 10.1016/j.jacc.2006.10.078 17481447 (Pubitemid 46661108)
16. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH, Neuromuscul Disord 2008 18 365 370 10.1016/j.nmd.2008.03.002 18436445
17. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM, J Am Coll Cardiol 2005 45 855 857 10.1016/j.jacc.2004.09.078 15766818 (Pubitemid 40342808)
18. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Becane HM, Am Heart J 2007 154 596 602 10.1016/j.ahj.2007.05.014 17719312 (Pubitemid 47268252)
19. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA, Circulation 2005 112 2799 2804 10.1161/CIRCULATIONAHA.104.528281 16246949 (Pubitemid 41641674)
20. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, et al. Lancet Neurol 2010 9 177 189 10.1016/S1474-4422(09)70272-8 19945914
21. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, et al. Lancet Neurol 2010 9 77 93 10.1016/S1474-4422(09)70271-6 19945913
22. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy. Cripe LH, Barber BJ, Spicer RL, Wong BL, Weidner N, Benson DW, Markham LW, Neuromuscul Disord 2006 16 745 748 10.1016/j.nmd.2006.07.021 17005398 (Pubitemid 44649223)
23. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Ashford MW Jr, Liu W, Lin SJ, Abraszewski P, Caruthers SD, Connolly AM, Yu X, Wickline SA, Circulation 2005 112 2462 2467 10.1161/CIRCULATIONAHA.104.516716 16216964 (Pubitemid 41504496)
24. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW, Gottliebson WM, J Am Coll Cardiol 2009 53 1204 1210 10.1016/j.jacc.2008.12.032 19341862
25. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Hagenbuch SC, Gottliebson WM, Wansapura J, Mazur W, Fleck R, Benson DW, Hor KN, Am J Cardiol 2010 105 1451 1455 10.1016/j.amjcard.2009.12.070 20451693
26. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, Eur Heart J 2004 25 1940 1965 10.1016/j.ehj.2004.06.040 15522474 (Pubitemid 39452612)
27. Clinical use of cardiovascular magnetic resonance. Pohost GM, Hung L, Doyle M, Circulation 2003 108 647 653 10.1161/01.CIR.0000083233.86078.3E 12912794 (Pubitemid 36999244)
28. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. Gotte MJ, Germans T, Russel IK, Zwanenburg JJ, Marcus JT, van Rossum AC, van Veldhuisen DJ, J Am Coll Cardiol 2006 48 2002 2011 10.1016/j.jacc.2006. 07.048 17112990 (Pubitemid 44738446)
29. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Osman NF, Kerwin WS, McVeigh ER, Prince JL, Magn Reson Med 1999 42 1048 1060 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0. CO;2-M 10571926
30. Imaging heart motion using harmonic phase MRI. Osman NF, McVeigh ER, Prince JL, IEEE Trans Med Imaging 2000 19 186 202 10.1109/42.845177 10875703
31. Regenerating MR tagged images using harmonic phase (HARP) methods. Osman NF, Prince JL, IEEE Trans Biomed Eng 2004 51 1428 1433 10.1109/TBME.2004.827932 15311829 (Pubitemid 38955166)
32. Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Garot J, Bluemke DA, Osman NF, Rochitte CE, McVeigh ER, Zerhouni EA, Prince JL, Lima JA, Circulation 2000 101 981 988 10704164 (Pubitemid 30131699)
33. Quantification in cardiac MRI. van der Geest RJ, Reiber JH, J Magn Reson Imaging 1999 10 602 608 10.1002/(SICI)1522-2586(199911)10:5<602::AID- JMRI3>3.0.CO;2-C 10548768 (Pubitemid 29519761)
34. Imaging longitudinal cardiac strain on short-axis images using strain-encoded MRI. Osman NF, Sampath S, Atalar E, Prince JL, Magn Reson Med 2001 46 324 334 10.1002/mrm.1195 11477637 (Pubitemid 32703279)
35. Visualizing myocardial function using HARP MRI. Osman NF, Prince JL, Phys Med Biol 2000 45 1665 1682 10.1088/0031-9155/45/6/318 10870717 (Pubitemid 30408925)
36. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Ennis DB, Epstein FH, Kellman P, Fananapazir L, McVeigh ER, Arai AE, Magn Reson Med 2003 50 638 642 10.1002/mrm.10543 12939774 (Pubitemid 37082091)
37. Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. Rosen BD, Saad MF, Shea S, Nasir K, Edvardsen T, Burke G, Jerosch-Herold M, Arnett DK, Lai S, Bluemke DA, Lima JA, J Am Coll Cardiol 2006 47 1150 1158 10.1016/j.jacc.2005.08.078 16545644
38. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N, Circulation 1994 90 854 867 8044957 (Pubitemid 24242755)
39. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD, Fierabracci A, Ugazio AG, Bottazzo GF, Heart 2004 90 1167 1171 10.1136/hrt.2003.026641 15367516 (Pubitemid 39279904)
40. Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy. Bauer R, Straub V, Blain A, Bushby K, MacGowan GA, Eur J Heart Fail 2009 11 463 471 10.1093/eurjhf/hfp028 19233868
41. Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA, Eur J Endocrinol 2010 162 331 340 10.1530/EJE-09-0621 19933822
42. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life. Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA, Am J Cardiol 2006 98 825 827 10.1016/j.amjcard.2006.04.020 16950195 (Pubitemid 44301021)
43. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Millay DP, Goonasekera SA, Sargent MA, Maillet M, Aronow BJ, Molkentin JD, Proc Natl Acad Sci USA 2009 106 19023 19028 10.1073/pnas.0906591106 19864620
44. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, Lemes V, J Heart Lung Transplant 1999 18 269 274 10.1016/S1053-2498(98)00030-8 10328154 (Pubitemid 29177904)
45. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Rhodes J, Margossian R, Darras BT, Colan SD, Jenkins KJ, Geva T, Powell AJ, Pediatr Cardiol 2008 29 343 351 10.1007/s00246-007-9113-z 17885779 (Pubitemid 351414875)
46. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, et al. JAMA 2007 298 1171 1179 10.1001/jama.298.10.1171 17848651 (Pubitemid 47403103)
47. Heart failure with normal ejection fraction (HFNEF): is it worth considering? Blanche C, Fumeaux T, Polikar R, Swiss Med Wkly 2010 140 66 72 20033859
48. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Burkhoff D, Maurer MS, Packer M, Circulation 2003 107 656 658 10.1161/01.CIR.0000053947.82595.03 12578861 (Pubitemid 36222586)
49. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. Hamdani N, Paulus WJ, van Heerebeek L, Borbely A, Boontje NM, Zuidwijk MJ, Bronzwaer JG, Simonides WS, Niessen HW, Stienen GJ, van der Velden J, Eur Heart J 2009 30 1863 1872 10.1093/eurheartj/ehp189 19487234
50. Telmisartan improves morphologic and functional changes in both left ventricular myocardium and carotid arterial wall in patients with hypertension: assessment by tissue Doppler imaging and carotid ultrasonography. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T, Echocardiography 2010 27 864 872 10.1111/j.1540-8175.2010.01163.x 20456478